News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD By Shelley Wood November 06, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT By Michael O'Riordan November 06, 2022
News Conference News AHA 2022 EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD By Todd Neale November 06, 2022
News Conference News AHA 2022 RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years By Yael L. Maxwell November 06, 2022
News Conference News AHA 2022 Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock By Caitlin E. Cox November 06, 2022
News Conference News AHA 2022 CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis By Yael L. Maxwell November 05, 2022
News Conference News AHA 2022 IRONMAN Misses but Lends Support to IV Iron Repletion in HF By Shelley Wood November 05, 2022
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE By Todd Neale November 05, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT By Michael O'Riordan November 05, 2022
News Conference News AHA 2022 TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF By Todd Neale November 05, 2022